LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the ...
LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution ...
LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the ...
(RTTNews) - T2 Biosystems, Inc. (TTOO) said it plans to commercialize the T2Lyme Panel in the third quarter of 2024 as a laboratory developed test without the need to be run on the T2Dx Instrument ...
July 7 (Reuters) - T2 Biosystems Inc : * T2 Biosystems Inc says for Q2 ended June 30, 2016, company closed six commitments, four domestically and two in international markets Sign up here. * Currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results